Mini reviewSARS-CoV-2 Mutations and their Viral Variants
Keywords
Cited by (0)
Dr. Devrim Demir Dora has graduated from Hacettepe University Faculty of Pharmacy in 1995 and got her Msc and PhD degree from Hacettepe University Graduate School of Health Sciences Pharmaceutical Biotechnology Program. She has worked as a Research Assistant at Hacettepe University Faculty of Pharmacy, Pharmaceutical Biotechnology Department from 1996 to 2005. Between 2005 and 2007, she has worked at Turkish Ministry of Health, General Directorate of Pharmaceuticals and Pharmacy, Quality Control Department, and she has participated in GMP Inspection team especially for the biotechnology derived products. She has worked as an Assistant Professor between 2007 and 2010 at Ege University Faculty of Pharmacy Department of Pharmaceutical Biotechnology and since 2010 at Akdeniz University Faculty of Medicine Department of Medical Pharmacology, Medical Biotechnology and Gene and Cell Therapy. Besides her academic duties, Dr. Demir Dora has been worked as ‘Advisory Board Member’ for approval of biotechnological/biosimilar medicinal products since 2009 at Turkish Medicines and Medical Devices Agency. Her areas of interest are recombinant protein production, regulation of biotechnological and biosimilar products, development of biopharmaceuticals, nanotechnology, advanced therapy medicinal products, gene therapy medicinal products, development of non viral nucleic acid delivery systems for gene therapy, cancer therapy, bacterial transformation, quorum sensing mechanism and genetic competence. She has ‘Bacterial Transformation Kit’ patent and three patent applications about non-viral gene delivery system for treatment of breast cancer and pseudomonas infection.